Aristocort and Temovate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aristocort (triamcinolone) and Temovate (clobetasol propionate). Common drug interactions include nausea among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Aristocort and Temovate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Aristocort?

Aristocort has active ingredients of triamcinolone. eHealthMe is studying from 508 Aristocort users. Check the latest studies of Aristocort.

What is Temovate?

Temovate has active ingredients of clobetasol propionate. eHealthMe is studying from 1,392 Temovate users. Check the latest studies of Temovate.



On Jul, 21, 2026

12 people who take Aristocort and Temovate together, and have interactions are studied.

Aristocort and Temovate drug interactions.

What are the common drug interactions of Aristocort and Temovate, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Peripheral swelling
  3. Bacteraemia (presence of bacteria in the blood)
  4. Capillary fragility increased
  5. Chest pain
  6. Dementia (madness)
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Drug hypersensitivity
  9. Dry eye (lack of adequate tears)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

male:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Nausea (feeling of having an urge to vomit)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Rhinovirus infection
  5. Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
  6. Diastolic dysfunction
  7. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Hepatic steatosis (fatty liver disease)
  10. Hypervolaemia (abnormally increased volume of blood)

What are the common drug interactions of Aristocort and Temovate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Capillary fragility increased
  2. Dry eye (lack of adequate tears)
  3. Lip dry
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Rhinovirus infection
  6. Scar
  7. Skin lesion

50-59:

n/a

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Peripheral swelling
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Hepatic steatosis (fatty liver disease)
  5. Hypervolaemia (abnormally increased volume of blood)
  6. Ileus (a painful obstruction of the ileum or other part of the intestine)
  7. Inappropriate antidiuretic hormone secretion
  8. Joint effusion (presence of extra fluid in joint covering)
  9. Muscle contractions involuntary (uncontrolled muscle contraction)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

What are the existing conditions these people have? *

  1. Pain: 4 people, 33.33%
  2. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
  3. Rashes (redness): 2 people, 16.67%
  4. Dyspnea (difficult or laboured breathing): 2 people, 16.67%
  5. Depression: 2 people, 16.67%
  6. Nausea And Vomiting: 2 people, 16.67%
  7. Constipation: 2 people, 16.67%
  8. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 16.67%
  9. Chest Pain: 2 people, 16.67%
  10. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aristocort and Temovate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aristocort and Temovate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aristocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temovate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aristocort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temovate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone and clobetasol propionate (the active ingredients of Aristocort and Temovate, respectively), and Aristocort and Temovate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: